Cargando…
Reply to a fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463111/ https://www.ncbi.nlm.nih.gov/pubmed/34571113 http://dx.doi.org/10.1016/j.ijcard.2021.09.043 |
_version_ | 1784572336510337024 |
---|---|
author | Leng, Wen-Xiu Yang, Yue-Jin |
author_facet | Leng, Wen-Xiu Yang, Yue-Jin |
author_sort | Leng, Wen-Xiu |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8463111 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84631112021-09-27 Reply to a fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era Leng, Wen-Xiu Yang, Yue-Jin Int J Cardiol Letter to the Editor Elsevier B.V. 2021-11-15 2021-09-25 /pmc/articles/PMC8463111/ /pubmed/34571113 http://dx.doi.org/10.1016/j.ijcard.2021.09.043 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Leng, Wen-Xiu Yang, Yue-Jin Reply to a fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era |
title | Reply to a fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era |
title_full | Reply to a fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era |
title_fullStr | Reply to a fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era |
title_full_unstemmed | Reply to a fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era |
title_short | Reply to a fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era |
title_sort | reply to a fibrinolysis-first strategy for st-elevation myocardial infarction in the covid-19 era |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463111/ https://www.ncbi.nlm.nih.gov/pubmed/34571113 http://dx.doi.org/10.1016/j.ijcard.2021.09.043 |
work_keys_str_mv | AT lengwenxiu replytoafibrinolysisfirststrategyforstelevationmyocardialinfarctioninthecovid19era AT yangyuejin replytoafibrinolysisfirststrategyforstelevationmyocardialinfarctioninthecovid19era |